Antiviral therapy for chronic hepatitis B: the imperative to move from scaling-up treatment to full treatment
10.3760/cma.j.cn501113-20230217-00064
- VernacularTitle:慢性乙型肝炎抗病毒治疗：从不断扩大治疗到全面治疗势在必行
- Author:
Qiuju SHENG
1
;
Xiaoguang DOU
Author Information
1. 中国医科大学附属盛京医院 辽宁省病毒性肝炎重点实验室，沈阳 110022
- Keywords:
Chronic hepatitis B;
Antiviral therapy;
Expanding indication and treat all
- From:
Chinese Journal of Hepatology
2023;31(3):225-227
- CountryChina
- Language:Chinese
-
Abstract:
Timely and effective antiviral therapy can prevent or delay the progression of the disease to cirrhosis, liver failure, or hepatocellular carcinoma in patients with chronic hepatitis B. Antiviral therapy indications are constantly expanding, and eventually it will be manageable to treat viral positives based on the new understanding of the disease progression and the changes in the definition of abnormal values in liver function tests.
